Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

426 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Glucose toxicity.
Yki-Järvinen H. Yki-Järvinen H. Endocr Rev. 1992 Aug;13(3):415-31. doi: 10.1210/edrv-13-3-415. Endocr Rev. 1992. PMID: 1425483 Review. No abstract available.
Non-alcoholic fatty liver disease and risk of type 2 diabetes.
Lallukka S, Yki-Järvinen H. Lallukka S, et al. Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):385-95. doi: 10.1016/j.beem.2016.06.006. Epub 2016 Jun 23. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27432073 Review.
The fatty liver and insulin resistance.
Yki-Järvinen H, Westerbacka J. Yki-Järvinen H, et al. Curr Mol Med. 2005 May;5(3):287-95. doi: 10.2174/1566524053766031. Curr Mol Med. 2005. PMID: 15892648 Review.
Type 2 diabetes: remission in just a week.
Yki-Järvinen H. Yki-Järvinen H. Diabetologia. 2011 Oct;54(10):2477-9. doi: 10.1007/s00125-011-2266-6. Epub 2011 Aug 9. Diabetologia. 2011. PMID: 21826485 No abstract available.
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension.
Yki-Järvinen H, Bergenstal RM, Bolli GB, Ziemen M, Wardecki M, Muehlen-Bartmer I, Maroccia M, Riddle MC. Yki-Järvinen H, et al. Diabetes Obes Metab. 2015 Dec;17(12):1142-9. doi: 10.1111/dom.12532. Epub 2015 Sep 14. Diabetes Obes Metab. 2015. PMID: 26172084 Free PMC article. Clinical Trial.
426 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page